| MeSH term | MeSH ID | Detail |
|---|---|---|
| Abnormalities, Multiple | D000015 | 13 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Arrhythmias, Cardiac | D001145 | 42 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Blister | D001768 | 16 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Bone Diseases | D001847 | 4 associated lipids |
| Brain Diseases | D001927 | 27 associated lipids |
| Brain Neoplasms | D001932 | 15 associated lipids |
| Breast Neoplasms | D001943 | 24 associated lipids |
| Calcinosis | D002114 | 5 associated lipids |
| Candidiasis | D002177 | 3 associated lipids |
| Carcinoma | D002277 | 18 associated lipids |
| Carcinoma, Basal Cell | D002280 | 6 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Carcinoma, Squamous Cell | D002294 | 14 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Cerebellar Neoplasms | D002528 | 9 associated lipids |
HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lu F et al. | Nuclear ING2 expression is reduced in human cutaneous melanomas. | 2006 | Br. J. Cancer | pmid:16755297 |
| Zhang GY et al. | Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. | 2005 | Br. J. Cancer | pmid:15583697 |
| Nieto Y et al. | Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. | 2007 | Br. J. Cancer | pmid:17609662 |
| Barshack I et al. | Spectral morphometric characterization of breast carcinoma cells. | 1999 | Br. J. Cancer | pmid:10188915 |
| Zaman MS et al. | The functional significance of microRNA-145 in prostate cancer. | 2010 | Br. J. Cancer | pmid:20588276 |
| Hu DE et al. | Early detection of tumour immune-rejection using magnetic resonance imaging. | 2003 | Br. J. Cancer | pmid:12671716 |
| Watson PH et al. | Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. | 2003 | Br. J. Cancer | pmid:12671706 |
| Alì G et al. | Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. | 2009 | Br. J. Cancer | pmid:19935800 |
| Overman MJ et al. | Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. | 2010 | Br. J. Cancer | pmid:19935793 |
| Zlobec I et al. | Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. | 2010 | Br. J. Cancer | pmid:19935791 |
| Aaltonen K et al. | Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. | 2006 | Br. J. Cancer | pmid:16670718 |
| Unger K et al. | RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. | 2006 | Br. J. Cancer | pmid:16641909 |
| Chinje EC et al. | 17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response. | 2002 | Br. J. Cancer | pmid:11857025 |
| Smith SL et al. | S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. | 2004 | Br. J. Cancer | pmid:15467767 |
| Caldwell GM et al. | Reorganisation of Wnt-response pathways in colorectal tumorigenesis. | 2008 | Br. J. Cancer | pmid:18414471 |
| Bridgewater J et al. | Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. | 2008 | Br. J. Cancer | pmid:18414470 |
| Darby S et al. | Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease. | 2009 | Br. J. Cancer | pmid:19888221 |
| Kato K et al. | Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. | 2008 | Br. J. Cancer | pmid:18665171 |
| Stumpf M et al. | Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. | 2009 | Br. J. Cancer | pmid:19861998 |
| Nam SY et al. | A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis. | 2011 | Br. J. Cancer | pmid:21119667 |
| Iijima H et al. | Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma. | 2004 | Br. J. Cancer | pmid:15292942 |
| Rajaganeshan R et al. | The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. | 2007 | Br. J. Cancer | pmid:17353920 |
| Palfi S et al. | Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. | 2004 | Br. J. Cancer | pmid:15292940 |
| Hibi K et al. | Methylation pattern of CDH13 gene in digestive tract cancers. | 2004 | Br. J. Cancer | pmid:15292927 |
| Suzuoki M et al. | Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. | 2002 | Br. J. Cancer | pmid:12402154 |
| Kikuchi R et al. | Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. | 2002 | Br. J. Cancer | pmid:12402153 |
| Connolly EM et al. | Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. | 2002 | Br. J. Cancer | pmid:12107848 |
| Tuynman JB et al. | Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma. | 2008 | Br. J. Cancer | pmid:18349821 |
| McCall P et al. | Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients. | 2008 | Br. J. Cancer | pmid:18349820 |
| Fritzsche F et al. | Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status. | 2006 | Br. J. Cancer | pmid:16434994 |
| Ino K et al. | Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. | 2006 | Br. J. Cancer | pmid:16434990 |
| Barnes N et al. | Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. | 2006 | Br. J. Cancer | pmid:16421596 |
| Le Page C et al. | Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. | 2006 | Br. J. Cancer | pmid:16421595 |
| Vizoso FJ et al. | Study of matrix metalloproteinases and their inhibitors in breast cancer. | 2007 | Br. J. Cancer | pmid:17342087 |
| West NP et al. | The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. | 2010 | Br. J. Cancer | pmid:20407439 |
| Kaneko K et al. | Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth. | 2004 | Br. J. Cancer | pmid:15213719 |
| Miyazono F et al. | Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. | 2004 | Br. J. Cancer | pmid:15213712 |
| Belien JA et al. | Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. | 2009 | Br. J. Cancer | pmid:19738619 |
| Salazar-Onfray F et al. | Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. | 2002 | Br. J. Cancer | pmid:12177778 |
| Fan Y et al. | Nucleostemin mRNA is expressed in both normal and malignant renal tissues. | 2006 | Br. J. Cancer | pmid:16670719 |
| Roche-Nagle G et al. | Antimetastatic activity of a cyclooxygenase-2 inhibitor. | 2004 | Br. J. Cancer | pmid:15213717 |
| Kabuubi P et al. | No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix. | 2006 | Br. J. Cancer | pmid:16317434 |
| Lin HJ et al. | Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. | 2005 | Br. J. Cancer | pmid:16288304 |
| Hu L et al. | Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. | 2010 | Br. J. Cancer | pmid:20354527 |
| Bjørge L et al. | Ascitic complement system in ovarian cancer. | 2005 | Br. J. Cancer | pmid:15726105 |
| Yokoyama Y and Ramakrishnan S | Improved biological activity of a mutant endostatin containing a single amino-acid substitution. | 2004 | Br. J. Cancer | pmid:15083196 |
| Grelier G et al. | Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. | 2009 | Br. J. Cancer | pmid:19672267 |
| Lau YS et al. | Malignant melanoma and bone resorption. | 2006 | Br. J. Cancer | pmid:16641914 |
| Ito Y et al. | Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. | 2002 | Br. J. Cancer | pmid:11953823 |
| Teo NB et al. | Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. | 2002 | Br. J. Cancer | pmid:11953822 |
| Al-Yasi AR et al. | Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1. | 2002 | Br. J. Cancer | pmid:11953817 |
| Mollevà DG et al. | PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. | 2008 | Br. J. Cancer | pmid:19002188 |
| Buffart TE et al. | MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. | 2008 | Br. J. Cancer | pmid:19002170 |
| Miyazaki T et al. | An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma. | 2004 | Br. J. Cancer | pmid:15467768 |
| Knight JF et al. | TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. | 2008 | Br. J. Cancer | pmid:19002168 |
| Koppert LB et al. | Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. | 2004 | Br. J. Cancer | pmid:14970870 |
| Jiao W et al. | Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. | 2002 | Br. J. Cancer | pmid:11857019 |
| Di Benedetto M et al. | Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. | 2003 | Br. J. Cancer | pmid:12799647 |
| Al-Saad S et al. | The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. | 2008 | Br. J. Cancer | pmid:18854838 |
| Jhavar S et al. | Construction of tissue microarrays from prostate needle biopsy specimens. | 2005 | Br. J. Cancer | pmid:16091762 |
| Dredge K et al. | Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. | 2002 | Br. J. Cancer | pmid:12402158 |
| Borle F et al. | Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. | 2003 | Br. J. Cancer | pmid:14676813 |
| Kusakari T et al. | C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. | 2003 | Br. J. Cancer | pmid:14676809 |
| Leonard P et al. | Gene expression array profile of human osteosarcoma. | 2003 | Br. J. Cancer | pmid:14676807 |
| Lo Muzio L et al. | Survivin expression in oral squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:14676801 |
| Jamieson SM et al. | Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity. | 2003 | Br. J. Cancer | pmid:12799641 |
| Duncan R et al. | Characterisation and protein expression profiling of annexins in colorectal cancer. | 2008 | Br. J. Cancer | pmid:18071363 |
| Stoeltzing O et al. | Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. | 2002 | Br. J. Cancer | pmid:12402160 |
| Tabori U et al. | Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. | 2008 | Br. J. Cancer | pmid:18797459 |
| Stecker K et al. | Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer. | 2011 | Br. J. Cancer | pmid:21468049 |
| Loussouarn D et al. | Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. | 2009 | Br. J. Cancer | pmid:19513072 |
| Klevesath MB et al. | The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. | 2005 | Br. J. Cancer | pmid:15942633 |
| Charalambous MP et al. | Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. | 2009 | Br. J. Cancer | pmid:19513071 |
| Atkin GK et al. | The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. | 2006 | Br. J. Cancer | pmid:17016487 |
| Matsubara J et al. | Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. | 2008 | Br. J. Cancer | pmid:18231104 |
| Nagourney RA et al. | Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics. | 2003 | Br. J. Cancer | pmid:14583785 |
| Inokuchi M et al. | Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. | 2003 | Br. J. Cancer | pmid:14583780 |
| Nakakubo Y et al. | Clinical significance of immune cell infiltration within gallbladder cancer. | 2003 | Br. J. Cancer | pmid:14583778 |
| Doak SH et al. | Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. | 2003 | Br. J. Cancer | pmid:14583777 |
| Radny P et al. | Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. | 2003 | Br. J. Cancer | pmid:14583759 |
| Bhoopathi P et al. | The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. | 2010 | Br. J. Cancer | pmid:20087345 |
| Mahalingam D et al. | Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. | 2010 | Br. J. Cancer | pmid:20087343 |
| Youssef MM et al. | EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer. | 2006 | Br. J. Cancer | pmid:16929248 |
| Bussolati G et al. | A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer. | 2005 | Br. J. Cancer | pmid:15812476 |
| Bugat R et al. | Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). | 2003 | Br. J. Cancer | pmid:12915904 |
| Rennel E et al. | The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. | 2008 | Br. J. Cancer | pmid:18349828 |
| Tsuji S et al. | Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. | 2010 | Br. J. Cancer | pmid:20628387 |
| Maruyama T et al. | Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma. | 2010 | Br. J. Cancer | pmid:20628381 |
| Polterauer S et al. | The impact of lymph node density on survival of cervical cancer patients. | 2010 | Br. J. Cancer | pmid:20628380 |
| Saeb-Parsy K et al. | MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3. | 2008 | Br. J. Cancer | pmid:18665176 |
| Caldwell GM et al. | Wnt signalling in adenomas of familial adenomatous polyposis patients. | 2010 | Br. J. Cancer | pmid:20628379 |
| Schimanski CC et al. | Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. | 2006 | Br. J. Cancer | pmid:16819541 |
| Van Laere SJ et al. | NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. | 2007 | Br. J. Cancer | pmid:17700572 |
| Kato T et al. | The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. | 2003 | Br. J. Cancer | pmid:12799634 |
| Yoshimoto M et al. | FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. | 2007 | Br. J. Cancer | pmid:17700571 |
| Arrieta O et al. | Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. | 2008 | Br. J. Cancer | pmid:18594540 |
| Koivunen JP et al. | Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. | 2008 | Br. J. Cancer | pmid:18594528 |
| Tischkowitz M et al. | Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness. | 2006 | Br. J. Cancer | pmid:16786041 |
| Nalwoga H et al. | Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. | 2010 | Br. J. Cancer | pmid:20010944 |
| Cao P et al. | Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts. | 2009 | Br. J. Cancer | pmid:19319133 |